Nottingham Clinical Trials Unit
The University of Nottingham
University of Nottingham
  • Print
  

STROKE-CARE

Trial Name:  Rapid Intervention with Glyceryl trinitrate in Hypersenstive stroke Trial-2 (RIGHT-2)

Chief Investigator:  Philip Bath, The University of Nottingham

Trial Description:  This trial is assessing the safety and efficacy of transdermal glyceryl trinitrate, a nitric oxide donor, and of the feasibility of a multicentre ambulance-based stroke trial. Total sample size is 850 participants. Recruitment opened in Septemer 2015. The primary outcome is death/dependence/independence: 7-level modified Rankin Scale (mRS) 90 days after stroke.

Contact:  Alan Montgomery

Funding:  British Heart Foundation

Status:  Recruiting

Publications: 2018-36

Further Information:   right-2@nottingham.ac.uk

 



UKCRC CTU Logo

Nottingham Clinical Trials Unit

General enquiries
Email: ctu@nottingham.ac.uk
Telephone: +44 (0)115 8231600